- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05002218
Training in Ataxia - Individuals With Degenerative Cerebellar Diseases
The Neural Effects of Balance Versus Aerobic Training in Individuals With Degenerative Cerebellar Diseases
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Degenerative cerebellar diseases are a group of disorders that cause severe disability and can be fatal. There are currently no known disease-modifying treatments available for use, and there is a critical need to find treatments that slow disease progression and allow affected individuals to live more functional lives. Balance and aerobic training show promise as treatments for degenerative cerebellar diseases, but the neural effects of both training methods have not been thoroughly investigated. It is crucial to understand how the training impacts the brain, and particularly the cerebellum, in order to determine if one training method is better at slowing disease progression than the other. The goal of this proposal is to compare the neural effects of balance versus aerobic training in individuals with degenerative cerebellar diseases. The investigator hypothesizes that aerobic training causes neuroplastic changes within the cerebellum whereas balance training causes improvements for people with cerebellar degeneration by impacting brain structures outside the cerebellum. If this hypothesis is true, aerobic training may have more influence on disease progression than balance training as it directly impacts the cerebellum.
To investigate the hypothesis, various neuroimaging techniques will be used. In AIM 1, the investigator will compare cerebellar volume before and after the participants perform either 6-months of balance or aerobic training. In AIM 2, the investigator will investigate whether neural changes have clinical significance by correlating cerebellar volume changes with clinical measures of ataxia. Finally, for AIM 3, the investigator will use diffusion tensor imaging and resting state fMRI scans to examine how both training methods impact cerebellar microstructure and functional cerebellar connections. The investigator hopes that a detailed understanding of how each training method impacts the cerebellum will lead to more targeted training regimens with the goal of slowing disease progression of these devastating diseases.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- Columbia University Irving Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosed with spinocerebellar ataxia
- Cerebellar atrophy on MRI
- Prevalence of ataxia on clinical exam
- Ability to safely ride a stationary exercise bike
Exclusion Criteria:
- Other neurologic conditions
- Heart disease
- Cognitive impairment
- Medical instability
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Aerobic Training
Participants will be given a stationary exercise bike for home use.
They will be instructed to use the exercise bike five times a week for thirty-minute sessions.
The exercise intensity prescription will be based on the subject's VO2max determined on pre-test day.
The exercise program will start at 60% of intensity per session, and then will be increased by steps of 5% intensity every 2 sessions until participants reach 30 minutes of training at 80% intensity.
Participants will be contacted weekly by e-mail or phone to answer any questions about the exercise protocol and will be instructed to log each training session.
Subjects will record duration of exercise, perceived exertion, average heart rate, maximum heart rate, and distance.
|
Aerobic training on stationary bike 5x a week for 30 minutes a day.
|
Active Comparator: Balance Training
A physical therapist will tailor a home balance training program for each participant based on pre- training capabilities.
Subjects will be asked to perform exercises five times a week for thirty-minute sessions.
Both dynamic and static exercises will be performed in sitting and standing positions.
Exercises will start with stabilizing in a challenging static position and progress to dynamic arm and leg movements in the same or modified position.
Participants will be contacted weekly by e-mail or phone to answer any questions about the exercise protocol and will be required to log their exercise effort in terms of frequency and level of balance challenge.
|
Balance training 5x a week for 30 minutes as instructed by a therapist.
Standard of care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Assessment and Rating of Ataxia (SARA) Score
Time Frame: Baseline, 6 months, 9 months, 12 months
|
This is to measure ataxia severity.
The Scale for the Assessment and Rating of Ataxia (SARA) will be administered before and after training.
SARA is an 8-item performance based scale, yielding a total score of 0 (no ataxia) to 40 (most severe ataxia) - with higher scores indicating ataxia.
The scores are based on patient performance of gait, stance, sitting, speech disturbance, finger chase, nose-finger test, fast alternating hand movements and heel-shin slide.
|
Baseline, 6 months, 9 months, 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Average gait speed
Time Frame: Baseline, 6 months, 9 months, 12 months
|
This is to measure average time to complete 8-meter walk test.
Participants will walk 8 meters as fast as possible three different times.
Time will be measured in seconds per meter.
|
Baseline, 6 months, 9 months, 12 months
|
Dynamic Gait Index score
Time Frame: Baseline, 6 months, 9 months, 12 months
|
The dynamic gait index (DGI) will be performed to asses balance.
A four-point ordinal scale, ranging from 0-3. "0" indicates the lowest level of function and "3" the highest level of function.
Total Score = 24.
Patients will be asked to walk 20 feet and conditions such as speed and head position will be varied as previously described.
The examiner will then grade the subject's movement.
|
Baseline, 6 months, 9 months, 12 months
|
Prevalence of desired changes in Diffuse Tensor Imaging
Time Frame: 6 months
|
Diffusion data will be preprocessed for motion and corrected for geometrical distortion using ExploreDTI.
For each participant, the bmatrix will be reoriented to provide a more accurate estimate of diffusion tensor orientations.
Diffusion tensor estimation will be performed using a non-linear least square fitting method.
FA and Mean Diffusivity (MD) maps will be generated.
Whole brain tractography will be performed using all brain voxels with FA ≤ 0.2 as seed region.
|
6 months
|
Prevalence of desired changes in Resting State fMRI scans
Time Frame: 6 months
|
This measure will be a primary outcome for Aim 3. The anatomical and functional data will be pre-processed and analyzed using Statistical Parametric Mapping (SPM12) and the CONN toolbox Version 14p.
|
6 months
|
Prevalence of Cerebellar Volume
Time Frame: Baseline, 6 months, 9 months, 12 months
|
To determine cerebellar volume, each T1 scan will be visually inspected to ensure inclusion of only minimal movement artifacts.
All images will be processed in a blinded manner in order to maintain accuracy and consistency of volume calculation.
Regional cerebellar volumes will be calculated using the SUIT toolbox of the SPM12 software.
|
Baseline, 6 months, 9 months, 12 months
|
Timed Up and Go
Time Frame: Baseline, 6 months, 9 months, 12 months
|
The Timed Up and Go will be performed to assess balance.
Participants will be asked to stand from seated and then walk around a cone that is 3 meters away.
Participants will then walk back to the chair and sit back down.
Participants will be timed.
|
Baseline, 6 months, 9 months, 12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Scott M Barbuto, MD, Assistant Professor of Rehabilitation and Regenerative Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AAAT8388
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebellar Ataxia
-
IRCCS Eugenio MedeaRecruiting
-
University Hospital, Strasbourg, FranceRecruitingAutosomal Recessive Cerebellar AtaxiaFrance
-
Universidade Federal de PernambucoActive, not recruitingAtaxia, CerebellarBrazil
-
Seoul National University HospitalCompletedAtaxia, Cerebellar | Ataxia, ProgressiveKorea, Republic of
-
Ataxia Study GroupGerman Center for Neurodegenerative Diseases (DZNE)RecruitingLate Onset Sporadic Cerebellar AtaxiaNorway, Austria, Germany, Netherlands, Italy
-
Hospices Civils de LyonRecruitingHealthy Volunteers | Optic AtaxiaFrance
-
University of California, Los AngelesRare Diseases Clinical Research Network; Office of Rare Diseases (ORD)CompletedCerebellar Diseases | Episodic Ataxia SyndromeUnited States, Canada, United Kingdom
-
General Hospital of Chinese Armed Police ForcesUnknownHereditary Cerebellar Ataxia.China
-
Ning Wang, MD., PhD.Recruiting
Clinical Trials on Aerobic Training
-
Riphah International UniversityRecruiting
-
University of BarcelonaCompleted
-
General Hospital Murska SobotaUniversity of Primorska; University of LjubljanaUnknownCoronary Artery Disease | Heart Failure With Reduced Ejection FractionSlovenia
-
Hadassah Medical OrganizationCompletedThe Influence of Different Training Regimens on Electrical Stability Following Myocardial InfarctionIschemic Heart Disease | Congestive Heart FailureIsrael
-
Riphah International UniversityCompletedMyocardial InfarctionPakistan
-
Riphah International UniversityCompleted
-
Clare MaguireRehab Basel; Bildungszetrum Gesundheit Basel-StadtCompleted
-
University of GiessenHannover Medical SchoolUnknownType 2 DiabetesGermany
-
Cardenal Herrera UniversityNot yet recruiting
-
UNC Lineberger Comprehensive Cancer CenterCompletedStem Cell Transplantation, HematopoieticUnited States